Development of preeclampsia provides a window of opportunity for early cardiovascular risk screening and intervention

Expert Review of Obstetrics and Gynecology

Volumn 4, Issue 4, 2009, Pages 355-357

  Smith, Graeme N ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; METABOLIC DISORDER; METABOLIC SYNDROME X; MICROANGIOPATHY; PREECLAMPSIA; PREVALENCE;

EID: 77951705234     PISSN: 17474108     EISSN: None     Source Type: Journal    
DOI: 10.1586/eog.09.16     Document Type: Editorial

References (29)

1. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. BMJ 335, 974 (2007). (Pubitemid 350144670)
2. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357, 2002-2006 (2001). (Pubitemid 32592386)
3. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366, 1797-1803 (2005).
4. Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study. Paediatr. Perinat. Epidemiol. 19, 59-68 (2005). (Pubitemid 40260794)
5. Manten GTR, Sikkema MJ, Voorbij HAM, Visser GHA, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens. Pregnancy 26, 39-50 (2007). (Pubitemid 46649339)
6. Forest J-C, Girouard J, Masse J et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet. Gynecol. 105, 1373-1380 (2005). (Pubitemid 40734272)
7. Smith GN, Walker M, Liu A et al. A history of preeclampsia identifes women who have underlying cardiovascular risk factors. Am. J. Obstet. Gynecol. 200, 58.e1-58.e8 (2009).
8. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome in pregnancy? Atherosclerosis 175, 189-202 (2004).
9. Roberts JM, Gammill H. Preeclampsia: recent insights. Hypertension 46, 1243-1249 (2005). (Pubitemid 43189714)
10. Ray JG. Metabolic syndrome and higher risk of maternal placental syndromes and cardiovascular disease. Drug Dev. Res. 67, 1-5 (2006).
11. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 23, 359-372 (2002).
12. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 30, 32-37 (2009).
13. Williams D. Pregnancy: a stress test for life. Curr. Opin. Obstet. Gynecol. 15, 465-471 (2003). (Pubitemid 38333555)
14. Irgens HU, Reisaeter L, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323, 1213-1217 (2001). (Pubitemid 33097312)
15. Roberts JM, Gammill H. Pre-eclampsia and cardiovascular disease in later life. Lancet 366, 961-962 (2005). (Pubitemid 41323014)
16. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Smith GD, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335, 978 (2007).
17. Parretti E, Lapolla A, Dalfra MG et al. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 47, 449-453 (2006). (Pubitemid 43740289)
18. Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet. Gynecol. 94, 543-550 (1999). (Pubitemid 29460937)
19. Ramsay JE, Ferrell WR, Crawford L, Wallace EM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and infammatory pathways. J. Clin. Endocrinol. Metab. 87(4231), 4237 (2002).
20. Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am. J. Med. Sci. 334, 291-295 (2007). (Pubitemid 351339288)
21. Bar J, Kaplan B, Wittenberg C et al. Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol. Dial. Transplant. 14, 1129-1132 (1999). (Pubitemid 29209296)
22. North RA, Simmons D, Barnfather D, Upjohn M. What happens to women with preeclampsia? Microalbuminuria and hypertension following pregnancy. Aust. NZ J. Obstet. Gynaecol. 36, 233-238 (1996). (Pubitemid 26278516)
23. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairement of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am. J. Physiol. Circ. Physiol. 286, H1389-H1393 (2004).
24. Ronnback M, Lampinen K, Groop P-H, Kaaja R. Pulse wave refection in currently and previously preeclamptic women. Hypertens. Pregnancy 24, 171-180 (2005). (Pubitemid 40911354)
25. Mosca L, Banka CL, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115, 1481-1501 (2007). (Pubitemid 46648385)
26. Tu K, Chen Z, Lipscombe LL; Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ 178, 1429-1435 (2008).
27. Leenen FHH, Dumais J, McInnis NH et al. Results of the Ontario Survey on the prevalence and control of hypertension. CMAJ 178, 1441-1449(2008). (Pubitemid 351775721)
28. MacDonald S, Smith GN, Godwin M, Walker M, Chen XK, Ramshaw H. Survey of obstetrical care providers understanding of long term risks and follow up of women with hypertensive disorders in pregnancy. J. Obstet. Gynaecol. Can. 29, 705-710 (2007).
29. Mosca L, Lindante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines in the United States. Circulation 111, 499-510 (2005). (Pubitemid 40204436)